Literature DB >> 33307312

Longitudinal analysis of T-cell receptor repertoires reveals persistence of antigen-driven CD4+ and CD8+ T-cell clusters in systemic sclerosis.

N H Servaas1, F Zaaraoui-Boutahar2, C G K Wichers1, A Ottria1, E Chouri1, A J Affandi1, S Silva-Cardoso1, M van der Kroef1, T Carvalheiro1, F van Wijk3, T R D J Radstake1, A C Andeweg2, A Pandit4.   

Abstract

The T-cell receptor (TCR) is a highly polymorphic surface receptor that allows T-cells to recognize antigenic peptides presented on the major histocompatibility complex (MHC). Changes in the TCR repertoire have been observed in several autoimmune conditions, and these changes are suggested to predispose autoimmunity. Multiple lines of evidence have implied an important role for T-cells in the pathogenesis of Systemic Sclerosis (SSc), a complex autoimmune disease. One of the major questions regarding the roles of T-cells is whether expansion and activation of T-cells observed in the diseases pathogenesis is antigen driven. To investigate the temporal TCR repertoire dynamics in SSc, we performed high-throughput sequencing of CD4+ and CD8+ TCRβ chains on longitudinal samples obtained from four SSc patients collected over a minimum of two years. Repertoire overlap analysis revealed that samples taken from the same individual over time shared a high number of TCRβ sequences, indicating a clear temporal persistence of the TCRβ repertoire in CD4+ as well as CD8+ T-cells. Moreover, the TCRβs that were found with a high frequency at one time point were also found with a high frequency at the other time points (even after almost four years), showing that frequencies of dominant TCRβs are largely consistent over time. We also show that TCRβ generation probability and observed TCR frequency are not related in SSc samples, showing that clonal expansion and persistence of TCRβs is caused by antigenic selection rather than convergent recombination. Moreover, we demonstrate that TCRβ diversity is lower in CD4+ and CD8+ T-cells from SSc patients compared with memory T-cells from healthy individuals, as SSc TCRβ repertoires are largely dominated by clonally expanded persistent TCRβ sequences. Lastly, using "Grouping of Lymphocyte Interactions by Paratope Hotspots" (GLIPH2), we identify clusters of TCRβ sequences with homologous sequences that potentially recognize the same antigens and contain TCRβs that are persist in SSc patients. In conclusion, our results show that CD4+ and CD8+ T-cells are highly persistent in SSc patients over time, and this persistence is likely a result from antigenic selection. Moreover, persistent TCRs form high similarity clusters with other (non-)persistent sequences that potentially recognize the same epitopes. These data provide evidence for an antigen driven expansion of CD4+/CD8+ T-cells in SSc.
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Autoimmunity; Longitudinal immunosequencing; Repertoire sequencing; Systemic sclerosis; T-cell receptor

Mesh:

Substances:

Year:  2020        PMID: 33307312     DOI: 10.1016/j.jaut.2020.102574

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  5 in total

1.  Contribution of HLA and KIR Alleles to Systemic Sclerosis Susceptibility and Immunological and Clinical Disease Subtypes.

Authors:  Aimee L Hanson; Joanne Sahhar; Gene-Siew Ngian; Janet Roddy; Jennifer Walker; Wendy Stevens; Mandana Nikpour; Shervin Assassi; Susanna Proudman; Maureen D Mayes; Tony J Kenna; Matthew A Brown
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

2.  Editorial: Etiopathogenesis of Systemic Sclerosis: An Update.

Authors:  Giuseppina Stifano; Raffaele De Palma
Journal:  Front Immunol       Date:  2021-03-22       Impact factor: 7.561

3.  Changes in T-cell subsets and clonal repertoire during chemoimmunotherapy with pembrolizumab and paclitaxel or capecitabine for metastatic triple-negative breast cancer.

Authors:  Brie Chun; Joanna Pucilowska; ShuChing Chang; Isaac Kim; Benjamin Nikitin; Yoshinobu Koguchi; William L Redmond; Brady Bernard; Venkatesh Rajamanickam; Nathan Polaske; Paul A Fields; Valerie Conrad; Mark Schmidt; Walter J Urba; Alison K Conlin; Heather L McArthur; David B Page
Journal:  J Immunother Cancer       Date:  2022-01       Impact factor: 13.751

Review 4.  Contributions of Immune Cells and Stromal Cells to the Pathogenesis of Systemic Sclerosis: Recent Insights.

Authors:  Bingying Dai; Liqing Ding; Lijuan Zhao; Honglin Zhu; Hui Luo
Journal:  Front Pharmacol       Date:  2022-02-03       Impact factor: 5.810

Review 5.  Reconstitution of the immune system and clinical correlates after stem cell transplantation for systemic sclerosis.

Authors:  Marianna Y Kawashima-Vasconcelos; Maynara Santana-Gonçalves; Djúlio C Zanin-Silva; Kelen C R Malmegrim; Maria Carolina Oliveira
Journal:  Front Immunol       Date:  2022-08-11       Impact factor: 8.786

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.